UnitedHealth Rises on Q1 Earnings Beat: ETFs to Gain

FHLC: Healthcare Dashboard For April

Weekly Market Pulse: Are Higher Interest Rates Good For The Economy?

Interest rates surged last week on the back of a hotter-than-expected inflation report. The rise in rates last week pushed the 10-year to its highest level since the peak at 5% in October of last year. Gold has been setting new highs, trading above $2400.

Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?

Weekly Report: what happened at FHLC last week (0408-0412)?

FHLC Enters Oversold Territory

Drug shortages in U.S. at highest level on record since 2001

Healthcare Drug shortages in U.S. At highest level on record since 2001 since 2001. Shortages are largely caused by supply chain disruptions due to natural disasters and manufacturing quality issues. 323 medications in short supply in Q1 2024, the highest on record for the American Society of Health-System Pharmacists.

Weekly Report: what happened at FHLC last week (0401-0405)?

FHLC: Large Outflows Detected at ETF

Weekly Report: what happened at FHLC last week (0325-0329)?

XLV: Fundamentals Don't Support Overweighting Health Care

The Health Care Select Sector SPDR ETF (XLV) tracks the 64 Health Care stocks in the S&P 500 Index. XLV's valuation is excessive and its growth potential could be better. The Sunday Investor Investing Group Leader does not recommend overweighting Health Care. XLv's best feature is its performance in major drawdowns.

Weekly Report: what happened at FHLC last week (0318-0322)?

Fidelity MSCI Health Care Index ETF declares quarterly distribution of $0.2380

Weekly Report: what happened at FHLC last week (0311-0315)?

Weekly Report: what happened at FHLC last week (0304-0308)?

Why Biotech Stocks May Be Ready For A Recovery

Biotech stocks have struggled in recent quarters as high interest rates take a toll on the capital-intensive sector. Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with MoneyTalk's Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a recovery.

Weekly Report: what happened at FHLC last week (0226-0301)?

Are Healthcare Stocks A Risky Prescription In A U.S. Election Year?

Weekly Report: what happened at FHLC last week (0219-0223)?

Sector Insights: What Could Go Right In 2024?